VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The role of navtemadlin in the MPN treatment landscape

In this video, Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, briefly discusses the role of navtemadlin in the treatment of myeloproliferative neoplasms (MPNs) and the mechanism of action of this agent. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Advisory boards for Novartis, Abbvie, BMS, AOP Orphan.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter